Account
Inquiry
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the natural GLP-1 hormone released in the gastrointestinal tract after eating. It functions by stimulating insulin production from the pancreas, which helps lower blood glucose levels. Initially developed for diabetes management, semaglutide has gained recognition for its effectiveness in promoting weight loss, making it a valuable tool in treating obesity as a chronic metabolic condition.
Clinical trials have demonstrated that semaglutide injections can lead to an average body weight reduction of 5-10% over a 68-week period. The semaglutide pen offers a convenient and precise method of administration, ensuring accurate dosing for research purposes. Its longer half-life compared to other GLP-1 agonists contributes to sustained effects and enhanced weight loss outcomes.
The benefits of using semaglutide include slowed gastric emptying, reduced liver glucose production, increased insulin secretion in response to high blood sugar, and appetite suppression. It also aids in improving lipid profiles by lowering triglyceride levels and oxidative stress associated with high LDL. Additionally, semaglutide promotes the conversion of white fat to brown fat, further supporting metabolic health.
This product is supplied as a high-purity peptide powder, ideal for laboratory and research applications. It is available in customizable strengths to meet specific study requirements. The semaglutide pen format ensures ease of use and consistency in dosing, making it suitable for various experimental setups.
Please note: This product is intended for research use only and is not for personal consumption. Proper handling and storage protocols should be followed to maintain integrity and efficacy.
